Frontlight ResearchEarly access
Taking people in United StatesNo phase
Social Functioning in Opioid Use Disorder
Key facts
- Who runs it
- Medical University of South Carolina
- Where
- Charleston, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 230 people, planned
- Started
- 13 Aug 2026
- Expected to end
- 31 Aug 2029
- Type of study
- Interventional
- Treatments tested
- CBT4CBT-Buprenorphine
- Record updated
- 17 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Any sex or gender; any race or ethnicity; aged 18 years or older
- Patient participants must meet DSM-5 diagnostic criteria for current (i.e., past 12 months) OUD (assessed via the Quick Structured Clinical Interview for DSM-5; Quick SCID)
- Patient participants must be on medication for opioid use disorder (MOUD), as prescribed by their provider, for no more than 12 weeks prior to study initiation
- Patient participants must be in treatment at a clinic in South Carolina
- Concurrent substance use disorders (e.g., alcohol, cannabis) for the patient participant are acceptable, provided opioids are the patient participant's primary substance of choice
- Patient participants must identify a CSO participant who consents to participation in the study as well
Who cannot take part
- Meeting DSM-5 criteria for a history of or current psychotic or bipolar disorders
- CSO participants meeting DSM-5 criteria for opioid use disorder or any other substance use disorder, excepting tobacco use disorder, mild cannabis use disorder, and mild alcohol use disorder
- Moderate-to-severe opioid withdrawal as defined by a score of ≥21 on the Subjective Opioid Withdrawal Scale
- Current suicidal or homicidal ideation and intent; participants who present a serious suicide risk are likely to require hospitalization during the study and they will be referred clinically
- Severe interpersonal violence in the past six months between the patient and the CSO, as defined by an adapted version of the Conflict Tactics Scaled Revised (CTS-2)
- Pregnancy for patient participants
- Prisoners, institutional individuals, and children will not be recruited for this study
This trial is currently available in United States.
- Medical University of South CarolinaCharleston, United StatesContact: Amber Jarnecke, PhDTaking people
About the trial
What the trial wants to find out
Problems with social functioning are core to opioid use disorder (OUD), though specific, modifiable social functioning targets and how they relate to OUD treatment outcomes are poorly understood. This study will utilize both data from both patients with OUD and their concerned significant other (CSO) to examine associations between specific social functioning metrics and OUD treatment outcomes. Findings from this study will inform future precision-medicine approaches for people with OUD, a population in significant need of enhanced treatment approaches to combat opioid morbidity and mortality.
The group in the trial
- CBT4CBT-BuprenorphineTreatment being tested
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Real-world Assessment of Social Functioning During OUD Treatment: Integrating Reports From Patients and Their Concerned Significant Others
- Record updated
- 17 August 2026